Properties of developed niosomal forms of anti-cancer substances N-hydroxy-2-(2-(naphthalen-2-yl)-1H-Indol-3-yl)-2-phenylacetamide in treatment of glioblastoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.